Maxair

Pirbuterol (trade name Maxair) is a short-acting β2 adrenoreceptor agonist with bronchodilating action used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler. It was patented in 1971 and came into medical use in 1983.[1] Contents 1 Medical use 2 Mode of action 3 Pharmacokinetics 4 Adverse effects 5 References 6 External links Medical use Pirbuterol is used in asthma for reversal of acute bronchospasm, and also ... [wikipedia]